{"log_id": 2517160062928534812, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 0, "average": 0.99964, "min": 0.998886}, "location": {"width": 85, "top": 250, "height": 25, "left": 226}, "words": "核准日期"}, {"probability": {"variance": 7e-06, "average": 0.998218, "min": 0.993775}, "location": {"width": 84, "top": 290, "height": 25, "left": 227}, "words": "修改日期"}, {"probability": {"variance": 3e-06, "average": 0.998683, "min": 0.995222}, "location": {"width": 387, "top": 326, "height": 49, "left": 429}, "words": "托珠单抗注射液说明书"}, {"probability": {"variance": 0, "average": 0.999844, "min": 0.999844}, "location": {"width": 28, "top": 365, "height": 26, "left": 1151}, "words": "药"}, {"probability": {"variance": 4.1e-05, "average": 0.997491, "min": 0.972022}, "location": {"width": 340, "top": 401, "height": 26, "left": 451}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 2e-06, "average": 0.998413, "min": 0.995669}, "location": {"width": 224, "top": 480, "height": 26, "left": 269}, "words": "警告:存在严重感染风险"}, {"probability": {"variance": 1.4e-05, "average": 0.998135, "min": 0.980783}, "location": {"width": 746, "top": 512, "height": 36, "left": 269}, "words": "接受托珠单抗治疗的患者发生严重感染的风险升高,可导致住院或死亡【见不良反"}, {"probability": {"variance": 2.9e-05, "average": 0.997228, "min": 0.972203}, "location": {"width": 696, "top": 554, "height": 31, "left": 230}, "words": "应】。发生这类感染的患者大多合并使用免疫抑制剂,如甲氨蝶呤或皮质类固醇"}, {"probability": {"variance": 0.000185, "average": 0.996225, "min": 0.928668}, "location": {"width": 521, "top": 595, "height": 29, "left": 270}, "words": "如发生严重感染,应中断托珠单抗治疗,直至感染得到控制"}, {"probability": {"variance": 4e-06, "average": 0.99878, "min": 0.993779}, "location": {"width": 146, "top": 637, "height": 25, "left": 270}, "words": "报告的感染包括"}, {"probability": {"variance": 7e-06, "average": 0.998588, "min": 0.987676}, "location": {"width": 718, "top": 669, "height": 35, "left": 299}, "words": "活动性结核,可表现为肺部疾病或肺外疾病。患者应在托珠单抗使用前和治疗期"}, {"probability": {"variance": 4e-06, "average": 0.998475, "min": 0.992438}, "location": {"width": 695, "top": 709, "height": 35, "left": 234}, "words": "间进行潜伏结核检查。如结果呈阳性,应在开始托珠单抗治疗前进行抗结核治疗"}, {"probability": {"variance": 0.000525, "average": 0.994075, "min": 0.863099}, "location": {"width": 715, "top": 750, "height": 29, "left": 301}, "words": "侵袭性真菌感染,包括念珠菌、曲菌、肺孢子虫感染。患有侵袭性真菌感染的患"}, {"probability": {"variance": 2e-06, "average": 0.998705, "min": 0.994587}, "location": {"width": 284, "top": 792, "height": 29, "left": 232}, "words": "者可表现为播散性而非局部感染"}, {"probability": {"variance": 2e-06, "average": 0.999099, "min": 0.99412}, "location": {"width": 340, "top": 831, "height": 27, "left": 303}, "words": "细菌感染、病毒感染和其他机会性感染"}, {"probability": {"variance": 3e-06, "average": 0.998826, "min": 0.990821}, "location": {"width": 698, "top": 866, "height": 32, "left": 274}, "words": "慢性或复发性感染患者在开始治疗前应仔细评估使用托珠单抗治疗的利益和风险"}, {"probability": {"variance": 1.4e-05, "average": 0.997351, "min": 0.98644}, "location": {"width": 743, "top": 904, "height": 36, "left": 275}, "words": "应密切监测患者在使用托珠单抗治疗期间和治疗后出现的感染症状和体征,包括治疗"}, {"probability": {"variance": 5e-06, "average": 0.99822, "min": 0.990386}, "location": {"width": 612, "top": 946, "height": 33, "left": 234}, "words": "前潜伏结核感染检查结果为阴性的患者可能发生的结核【见注意事项】"}, {"probability": {"variance": 2e-06, "average": 0.99901, "min": 0.996125}, "location": {"width": 110, "top": 1030, "height": 25, "left": 243}, "words": "【药品名称】"}, {"probability": {"variance": 1.5e-05, "average": 0.997892, "min": 0.985298}, "location": {"width": 244, "top": 1067, "height": 26, "left": 277}, "words": "通用名称:托珠单抗注射液"}, {"probability": {"variance": 7e-06, "average": 0.998303, "min": 0.992607}, "location": {"width": 279, "top": 1104, "height": 28, "left": 277}, "words": "商品名称:雅美罗 ACTEMRA"}, {"probability": {"variance": 5.1e-05, "average": 0.992958, "min": 0.97948}, "location": {"width": 257, "top": 1146, "height": 24, "left": 279}, "words": "英文名称: Tocilizumab Injecti"}, {"probability": {"variance": 0.011162, "average": 0.932179, "min": 0.740223}, "location": {"width": 261, "top": 1185, "height": 26, "left": 278}, "words": "汉语拼音: Tuozhudankang Zhu"}, {"probability": {"variance": 3.9e-05, "average": 0.993567, "min": 0.983638}, "location": {"width": 69, "top": 1224, "height": 27, "left": 248}, "words": "【成份】"}, {"probability": {"variance": 4e-06, "average": 0.998111, "min": 0.993293}, "location": {"width": 221, "top": 1262, "height": 26, "left": 281}, "words": "主要活性成分:托珠单抗"}, {"probability": {"variance": 0.016006, "average": 0.967702, "min": 0.357141}, "location": {"width": 745, "top": 1296, "height": 33, "left": 282}, "words": "托珠单抗是一种重组人源化抗人白介素6(-6)受体单克隆抗体,由中国仓鼠卵巢"}, {"probability": {"variance": 0.012422, "average": 0.957327, "min": 0.576923}, "location": {"width": 325, "top": 1340, "height": 28, "left": 253}, "words": "(CHO)细胞通过DNA重组技术制得"}, {"probability": {"variance": 0.017705, "average": 0.923254, "min": 0.497467}, "location": {"width": 406, "top": 1378, "height": 29, "left": 282}, "words": "分子式:C6428H7N7202018S42(仅多肽部分)"}, {"probability": {"variance": 0.015761, "average": 0.484431, "min": 0.354527}, "location": {"width": 118, "top": 1339, "height": 57, "left": 819}, "words": "份分"}, {"probability": {"variance": 0.002116, "average": 0.983091, "min": 0.804532}, "location": {"width": 297, "top": 1419, "height": 27, "left": 283}, "words": "分子量:144985Da(仅多肽部分"}, {"probability": {"variance": 0.001241, "average": 0.985769, "min": 0.836534}, "location": {"width": 700, "top": 1453, "height": 35, "left": 283}, "words": "辅料包括:蔗糖、聚山梨酯80、十二水合磷酸氢二钠、二水合磷酸二氢钠和注射"}, {"probability": {"variance": 0.006553, "average": 0.878999, "min": 0.79805}, "location": {"width": 98, "top": 1449, "height": 43, "left": 985}, "words": "份香"}, {"probability": {"variance": 1e-06, "average": 0.999011, "min": 0.997659}, "location": {"width": 72, "top": 1499, "height": 25, "left": 250}, "words": "【性状】"}, {"probability": {"variance": 0, "average": 0.826289, "min": 0.826289}, "location": {"width": 40, "top": 1496, "height": 32, "left": 1095}, "words": "武"}, {"probability": {"variance": 8.7e-05, "average": 0.995408, "min": 0.961225}, "location": {"width": 302, "top": 1536, "height": 26, "left": 284}, "words": "澄清至半透明的无色至淡黄色液体"}, {"probability": {"variance": 0, "average": 0.999247, "min": 0.999247}, "location": {"width": 72, "top": 1519, "height": 71, "left": 1005}, "words": "★"}], "language": 3}